
Antibody prevalence and immunotherapy response in Chinese patients with epilepsy and encephalopathy scores for patients with different neuronal surface antibodies
Author(s) -
Yu Ji,
HuiFang Wang,
Mengyao Zhang,
Yuping Wang
Publication year - 2021
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001701
Subject(s) - medicine , epilepsy , antibody , encephalopathy , immunotherapy , myelin oligodendrocyte glycoprotein , gastroenterology , immunology , immune system , experimental autoimmune encephalomyelitis , psychiatry
The scale assessment was helpful in predicting the presence of antibodies to autoimmune encephalitis. This study aimed to evaluate the application of antibody prevalence in Chinese patients with epilepsy and encephalopathy (APE2-CHN) and response to immunotherapy in Chinese patients with epilepsy and encephalopathy (RITE2-CHN) for patients with different neuronal surface antibodies.